These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 6370241)

  • 21. Low-molecular weight C1q-binding immunoglobulin G in patients with systemic lupus erythematosus consists of autoantibodies to the collagen-like region of C1q.
    Uwatoko S; Mannik M
    J Clin Invest; 1988 Sep; 82(3):816-24. PubMed ID: 3262124
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Localisation of the C1q binding site within C1q receptor/calreticulin.
    Stuart GR; Lynch NJ; Lu J; Geick A; Moffatt BE; Sim RB; Schwaeble WJ
    FEBS Lett; 1996 Nov; 397(2-3):245-9. PubMed ID: 8955356
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of the zinc-dependent endothelial cell binding protein for high molecular weight kininogen and factor XII: identity with the receptor that binds to the globular "heads" of C1q (gC1q-R).
    Joseph K; Ghebrehiwet B; Peerschke EI; Reid KB; Kaplan AP
    Proc Natl Acad Sci U S A; 1996 Aug; 93(16):8552-7. PubMed ID: 8710908
    [TBL] [Abstract][Full Text] [Related]  

  • 24. C1q--how many functions? How many receptors?
    Eggleton P; Reid KB; Tenner AJ
    Trends Cell Biol; 1998 Nov; 8(11):428-31. PubMed ID: 9854308
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of the Raji cell membrane-derived C1q inhibitor as a receptor for human C1q. Purification and immunochemical characterization.
    Ghebrehiwet B; Silvestri L; McDevitt C
    J Exp Med; 1984 Nov; 160(5):1375-89. PubMed ID: 6436431
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cell-surface protein identified on phagocytic cells modulates the C1q-mediated enhancement of phagocytosis.
    Guan E; Robinson SL; Goodman EB; Tenner AJ
    J Immunol; 1994 Apr; 152(8):4005-16. PubMed ID: 8144968
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human leukocyte C1q receptor binds other soluble proteins with collagen domains.
    Malhotra R; Thiel S; Reid KB; Sim RB
    J Exp Med; 1990 Sep; 172(3):955-9. PubMed ID: 2388038
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human C1qRp is identical with CD93 and the mNI-11 antigen but does not bind C1q.
    McGreal EP; Ikewaki N; Akatsu H; Morgan BP; Gasque P
    J Immunol; 2002 May; 168(10):5222-32. PubMed ID: 11994479
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The complement subcomponent C1q mediates binding of immune complexes and aggregates to endothelial cells in vitro.
    Daha MR; Miltenburg AM; Hiemstra PS; Klar-Mohamad N; Van Es LA; Van Hinsbergh VW
    Eur J Immunol; 1988 May; 18(5):783-7. PubMed ID: 3259929
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Soluble gC1q-R/p33, a cell protein that binds to the globular "heads" of C1q, effectively inhibits the growth of HIV-1 strains in cell cultures.
    Szabó J; Cervenák L; Tóth FD; Prohászka Z; Horváth L; Kerekes K; Beck Z; Bácsi A; Erdei A; Peerschke EI; Füst G; Ghebrehiwet B
    Clin Immunol; 2001 May; 99(2):222-31. PubMed ID: 11318594
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Platelet C1q receptor interactions with collagen- and C1q-coated surfaces.
    Peerschke EI; Ghebrehiwet B
    J Immunol; 1990 Nov; 145(9):2984-8. PubMed ID: 2212670
    [TBL] [Abstract][Full Text] [Related]  

  • 32. C1Q, a subunit of the first component of complement, enhances the binding of aggregated IgG to rat renal mesangial cells.
    van den Dobbelsteen ME; van der Woude FJ; Schroeijers WE; Klar-Mohamad N; van Es LA; Daha MR
    J Immunol; 1993 Oct; 151(8):4315-24. PubMed ID: 8409404
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Participation of C1q and its receptor in adherence of human diploid fibroblast.
    Bordin S; Ghebrehiwet B; Page RC
    J Immunol; 1990 Oct; 145(8):2520-6. PubMed ID: 2212651
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhanced binding and degradation of the C1q subcomponent of complement by thioglycollate-stimulated guinea pig peritoneal macrophages.
    Veerhuis R; Klar-Mohamad N; van Es LA; Daha MR
    Scand J Immunol; 1986 May; 23(5):581-7. PubMed ID: 3486466
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human lung fibroblast subpopulations with different C1q binding and functional properties.
    Akamine A; Raghu G; Narayanan AS
    Am J Respir Cell Mol Biol; 1992 Apr; 6(4):382-9. PubMed ID: 1550683
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exposure of human epidermal keratinocyte cell cultures to sulfur mustard promotes binding of complement C1q: implications for toxicity and medical countermeasures.
    Cowan FM; Broomfield CA; Smith WJ
    J Appl Toxicol; 2000 Dec; 20 Suppl 1():S77-80. PubMed ID: 11428648
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of a novel 33-kDa C1q-binding site on human blood platelets.
    Peerschke EI; Reid KB; Ghebrehiwet B
    J Immunol; 1994 Jun; 152(12):5896-901. PubMed ID: 8207215
    [TBL] [Abstract][Full Text] [Related]  

  • 38. C1q receptor.
    Ghebrehiwet B
    Methods Enzymol; 1987; 150():558-78. PubMed ID: 3123878
    [No Abstract]   [Full Text] [Related]  

  • 39. Characterization of C1q-binding material released from the membranes of Raji and U937 cells by limited proteolysis with trypsin.
    Erdei A; Reid KB
    Biochem J; 1988 Oct; 255(2):493-9. PubMed ID: 3144267
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of the human C1q receptor.
    Erdei A; Reid KB
    Behring Inst Mitt; 1989 Jul; (84):216-9. PubMed ID: 2679534
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.